Grifols S.A.
Develops and produces plasma-derived medicines and biopharmaceutical solutions.
GRF | MC
Overview
Corporate Details
- ISIN(s):
- ES0171996087 (+4 more)
- LEI:
- 959800HSSNXWRKBK4N60
- Country:
- Spain
- Address:
- Avenida de la Generalitat 152-158, 08174 Sant Cugat del Vallès
- Website:
- https://www.grifols.com/en/home
- Sector:
- Manufacturing
Description
Grifols S.A. is a global healthcare company specializing in the development, production, and marketing of plasma-derived medicines and other biopharmaceutical solutions. As a leading producer of therapies derived from human plasma, the company addresses the needs of patients with chronic, rare, and life-threatening conditions. Its core activities encompass the entire plasma value chain, from collection to the manufacturing of essential protein therapies. In addition to its primary Biopharma division, Grifols provides a comprehensive portfolio of diagnostic solutions for transfusion medicine and clinical laboratories, as well as bio supplies for pharmaceutical and research applications. The company is committed to advancing patient health and well-being through scientific innovation and high standards of quality and safety.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2023-06-14 09:18 |
Información Privilegiada.
|
Spanish | 17.0 KB | ||
| 2023-05-12 08:18 |
Convocatoria de la Junta General Ordinaria 2023 de Grifols, S.A.
|
Spanish | 162.3 KB | ||
| 2023-05-10 17:46 |
La Sociedad informa que el Consejo de Administración ha aprobado un plan de inc…
|
Spanish | 100.5 KB | ||
| 2023-05-09 08:10 |
Grifols anuncia la información financiera del primer trimestre de 2023
|
Spanish | 764.9 KB | ||
| 2023-05-08 08:03 |
Nueva estructura de dirección.
|
Spanish | 41.4 KB | ||
| 2023-04-18 17:38 |
Reorganización del Comité de Auditoría de la Sociedad.
|
Spanish | 44.4 KB | ||
| 2023-02-28 08:20 |
Grifols remite información del segundo semestre de 2022
|
Spanish | 957.5 KB | ||
| 2023-02-28 00:00 | Spanish | 1.8 MB | |||
| 2023-02-28 00:00 | English | 15.0 MB | |||
| 2023-02-28 00:00 | Spanish | 59.8 MB | |||
| 2023-02-24 12:14 |
El Consejo de Administración ha acordado, en su reunión de fecha 23 de febrero …
|
Spanish | 220.4 KB | ||
| 2023-02-24 00:00 |
Corporate Governance Report - Grifols S.A.
|
Spanish | 233.6 KB | ||
| 2023-02-21 17:48 |
Grifols comunica cambios en la composición de su Consejo y Comisiones.
|
Spanish | 45.7 KB | ||
| 2023-02-15 17:38 |
Grifols ha aprobado un plan integral de mejoras operativas diseñado para reforz…
|
Spanish | 43.5 KB | ||
| 2022-10-21 13:53 |
Comunicado de Grifols sobre información publicada por algunos medios españoles
|
Spanish | 92.4 KB |
Automate Your Workflow. Get a real-time feed of all Grifols S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grifols S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grifols S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
